Antag Therapeutics ApS
38402056ActivePioneering novel GIP receptor antagonist therapies for treating chronic obesity.
Oversikt
- 7
- Ansatte
- Ukjent
- Omsetning
- 2017
- Grunnlagt
Nøkkelbeslutningstakere
Jens Juul Holst
Founder and Professor
Philip Just Larsen
Chief Executive Officer
Mette Rosenkilde
Founder and Professor
Beskrivelse
Antag Therapeutics is a clinical-stage biopharmaceutical company based in Copenhagen, Denmark, dedicated to redefining the treatment of obesity and metabolic disorders. The company focuses on pioneering a novel class of therapies through GIP receptor antagonism to address the limitations of current...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Ukjent
- Juridisk form
- APS
- MVA-nummer
- DK38402056
Beslutningstakere
3 kontakter i FunnelfeedrJens Juul Holst
Founder and Professor
Philip Just Larsen
Chief Executive Officer
Mette Rosenkilde
Founder and Professor
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrAlveus Therapeutics ApS
12 ansatteClinical-stage biotech developing next-generation therapies for obesity and metabolic diseases.
ZEALAND PHARMA A/S
520 ansatteInnovative biotechnology company developing peptide-based medicines for metabolic health.
ASCENDIS PHARMA A/S
629 ansatteGlobal biopharmaceutical company developing innovative therapies using proprietary TransCon technology.
Pephexia Therapeutics ApS
5 ansatteDeveloping innovative peptide-based therapies for treating cachexia and sarcopenia.
ZEALAND PHARMA A/S
0 ansatteDeveloping peptide medicines for metabolic health challenges globally.
Utforsk mer
Spørsmål om Antag Therapeutics ApS
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo